Nexcelom recognized as a Top Drug Discovery and Development solutions provider of 2021
Pharma Tech Outlook has recently recognized Nexcelom Bioscience as a Top Drug Discovery and Development solutions provider of 2021, noting us as “pioneers reshaping the future of cell counting and analysis through innovation and expertise in image cytometry”.
Collaborating amongst working academics and scientists, Nexcelom strives at delivering fit-for-purpose cell counting solutions for countless applications and various cell samples. We offer guidance in the form of numerous educational webinars, white papers, and relevant presentations including a Practical Application of ISO Cell Counting Standards to Improve the Quality of Cell Counting Measurements”. Additionally, our advanced Celigo Image Cytometer and Cellaca MX High-throughput Automated Cell Counter systems can count a large number of samples in just a few minutes to rapidly address a wide variety of critical cell counting and measurement needs with optional add-ons including 21 CFR Part 11 ready audit trails, user access controls, and digital signatures.
Our CEO Peter Y Li Ph.D. was quoted in the feature stating “Our organization doesn’t just look at cell counting as a routine task as people have done in the past. For creating accurate and reliable cell counting methods and solutions, we have been building a scientific foundation through engaging collaborations with our customers,” expressing his passion for our products he adds “We deliver high-quality, reliable products using image cytometry technology, addressing a wide variety of critical cell counting and measurement applications”.